Calcium channel expression and applicability as targeted therapies in melanoma

A Macià1, J Herreros1, R M Martí2

  • 1University of Lleida-IRBLleida, 25198 Lleida, Spain.

Insights

Calcium (Ca2+) signaling alterations are crucial in melanoma, affecting cell growth and survival. Targeting Ca2+ channels in melanoma cells offers potential as prognostic markers and therapeutic strategies.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Calcium (Ca2+) signaling is frequently altered in cancer, promoting cancer cell proliferation, migration, and survival under stress.
  • Changes in Ca2+ fluxes across the plasma membrane are a key aspect of these adaptive mechanisms in cancer cells.

Purpose of the Study:

  • To review current knowledge on Ca2+ channel expression in melanoma plasma membranes.
  • To explore the impact of these channels on oncogenic Ca2+ signaling in melanoma.
  • To highlight potential roles in melanoma progression and therapeutic strategies.

Main Methods:

  • Literature review of studies on Ca2+ channels in melanoma.
  • Analysis of molecular components involved in Ca2+ influx pathways.
  • Investigation of links between Ca2+ homeostasis and melanoma cell processes.

Main Results:

  • Identified new molecular components of Ca2+ influx pathways in melanoma cells.
  • Unveiled new connections between Ca2+ homeostasis and melanoma tumor progression.
  • Ca2+ channels show potential as prognostic markers.

Conclusions:

  • Ca2+ channels play a significant role in melanoma pathophysiology.
  • Pharmacological blockade or gene silencing of Ca2+ channels are promising therapeutic avenues for melanoma.
  • Understanding Ca2+ channel function is critical for developing novel melanoma treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K